Cargando…
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227595/ https://www.ncbi.nlm.nih.gov/pubmed/32425250 http://dx.doi.org/10.1016/j.therap.2020.05.005 |
_version_ | 1783534530834989056 |
---|---|
author | Montastruc, François Romano, Charles Montastruc, Jean-Louis Silva, Stein Seguin, Thierry Minville, Vincent Georges, Bernard Riu-Poulenc, Béatrice Fourcade, Olivier |
author_facet | Montastruc, François Romano, Charles Montastruc, Jean-Louis Silva, Stein Seguin, Thierry Minville, Vincent Georges, Bernard Riu-Poulenc, Béatrice Fourcade, Olivier |
author_sort | Montastruc, François |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7227595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72275952020-05-18 Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France Montastruc, François Romano, Charles Montastruc, Jean-Louis Silva, Stein Seguin, Thierry Minville, Vincent Georges, Bernard Riu-Poulenc, Béatrice Fourcade, Olivier Therapie Article Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2020 2020-05-15 /pmc/articles/PMC7227595/ /pubmed/32425250 http://dx.doi.org/10.1016/j.therap.2020.05.005 Text en © 2020 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Montastruc, François Romano, Charles Montastruc, Jean-Louis Silva, Stein Seguin, Thierry Minville, Vincent Georges, Bernard Riu-Poulenc, Béatrice Fourcade, Olivier Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France |
title | Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France |
title_full | Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France |
title_fullStr | Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France |
title_full_unstemmed | Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France |
title_short | Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France |
title_sort | pharmacological characteristics of patients infected with sars-cov-2 admitted to intensive care unit in south of france |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227595/ https://www.ncbi.nlm.nih.gov/pubmed/32425250 http://dx.doi.org/10.1016/j.therap.2020.05.005 |
work_keys_str_mv | AT montastrucfrancois pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance AT romanocharles pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance AT montastrucjeanlouis pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance AT silvastein pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance AT seguinthierry pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance AT minvillevincent pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance AT georgesbernard pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance AT riupoulencbeatrice pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance AT fourcadeolivier pharmacologicalcharacteristicsofpatientsinfectedwithsarscov2admittedtointensivecareunitinsouthoffrance |